Analysis of BPD in Premature Infants With Typical Imaging Changes
NCT04163822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 256
Last updated 2023-04-04
Summary
Bronchopulmonary dysplasia (BPD) is a common chronic respiratory disease in preterm infants. The increase in the survival rate of premature babies following the improvement of perinatal treatment and care has caused an increase in the incidence of BPD in recent years, which has seriously affected the quality of life of preterm infants. According to the consensus reached at the workshop sponsored by the National Institute of Child Health and Human Development (NICHD) in 2001, BPD was clinically defined based on oxygen dependency in preterm infants. However, the refined NICHD definition of BPD in 2018 emphasizes imaging findings to support a diagnosis of lung parenchyma disease.
Fibrotic opacities and cystic changes on chest imaging (chest X-ray \[CXR\] or computed tomography \[CT\] scan) were considered typical findings in BPD patients. In patients with severe BPD, the presence of bubbles/cystic appearance on CXR after 28 days of life was reported to be an important factor, and typical imaging findings can predict a poor pulmonary outcome in BPD patients. BPD is associated with poor outcomes. Although many studies have been conducted on BPD, there are limited reports specifically evaluating the association of typical imaging findings with clinical characteristics and later outcomes in patients with BPD.
We hypothesized that BPD with typical imaging findings was likely to be a particular subgroup of this entity, with a unique etiology, clinical characteristics and prognosis. Therefore, this retrospective study aimed to compare clinical characteristics, short-term outcomes and follow-up data until 2 years of age in preterm infants with or without typical imaging findings of BPD on CXR or CT scan during the entire hospital stay. A propensity score analysis was used to reduce bias between the two groups, and multivariate logistic regression analysis was performed to identify factors related to mortality in preterm infants with BPD.
Conditions
- Bronchopulmonary Dysplasia
Interventions
- OTHER
-
no intervention
no intervention, only observation
Sponsors & Collaborators
-
Wang Jianhui
lead OTHER
Principal Investigators
-
Yuan Shi, M.D · Children's Hospital of Chongqing Medical University
Eligibility
- Max Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2021-04-30
- Completion
- 2021-05-20
Countries
- China
Study Locations
More Related Trials
-
Biomarkers and Volumetric Capnography in BPD
NCT02083562 ·Status: COMPLETED
-
GER Poses a Potential Risk for Late Complications of BPD
NCT03014453 ·Status: COMPLETED
-
Body Weight Growth After Birth and Bronchopulmonary Dysplasia
NCT05053269 ·Status: WITHDRAWN
-
MRI in BPD Subjects
NCT03657693 ·Status: RECRUITING
-
Stem Cells for Bronchopulmonary Dysplasia
NCT03378063 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
NCT00005289 ·Status: COMPLETED
-
The Baby Lung Study
NCT05152316 ·Status: COMPLETED
-
Antecedents of Bronchopulmonary Dysplasia
NCT00005293 ·Status: COMPLETED
-
p16Ink4a in Bronchopulmonary Dysplasia in Children
NCT03540680 ·Status: UNKNOWN ·Phase: NA
-
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
NCT01516398 ·Status: COMPLETED
-
The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms
NCT03855202 ·Status: UNKNOWN ·Phase: PHASE1
-
Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation
NCT04209088 ·Status: UNKNOWN ·Phase: NA
-
Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia
NCT03538977 ·Status: UNKNOWN ·Phase: NA
-
Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants
NCT00904774 ·Status: UNKNOWN
-
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
NCT04971694 ·Status: COMPLETED
-
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
NCT04756297 ·Status: COMPLETED
-
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
NCT00067613 ·Status: COMPLETED ·Phase: NA
-
Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD
NCT04905732 ·Status: UNKNOWN ·Phase: NA
-
Duodenal Feeds in Very Low Birth Weight Infants
NCT04246333 ·Status: COMPLETED ·Phase: NA
-
Right vEntricular Function Prediction mOdel to Identify pReterm infanTs With Early BronchoPulmonary Dysplasia.
NCT05235399 ·Status: COMPLETED
-
Point of Care Lung Ultrasound in Preterm Infants With Respiratory Distress
NCT05925075 ·Status: ENROLLING_BY_INVITATION
-
Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
NCT04890158 ·Status: TERMINATED ·Phase: NA
-
The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)
NCT06342752 ·Status: RECRUITING
-
Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies
NCT02443961 ·Status: COMPLETED ·Phase: PHASE1
-
Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)
NCT03311165 ·Status: COMPLETED